Artigos de revistas sobre o tema "Anti-HCoV-229E activity"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 40 melhores artigos de revistas para estudos sobre o assunto "Anti-HCoV-229E activity".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Hakem, Asma, Lowiese Desmarets, Ramla Sahli, Rawen Ben Malek, Charline Camuzet, Nathan François, Gabriel Lefèvre et al. "Luteolin Isolated from Juncus acutus L., a Potential Remedy for Human Coronavirus 229E". Molecules 28, n.º 11 (23 de maio de 2023): 4263. http://dx.doi.org/10.3390/molecules28114263.
Texto completo da fonteParang, Keykavous, Naglaa Salem El-Sayed, Assad J. Kazeminy e Rakesh K. Tiwari. "Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)". Molecules 25, n.º 10 (17 de maio de 2020): 2343. http://dx.doi.org/10.3390/molecules25102343.
Texto completo da fonteChang, Fang-Rong, Chiao-Ting Yen, Mohamed EI-Shazly, Wen-Hsun Lin, Ming-Hong Yen, Kuei-Hsiang Lin e Yang-Chang Wu. "Anti-Human Coronavirus (anti-HCoV) Triterpenoids from the Leaves of Euphorbia Neriifolia". Natural Product Communications 7, n.º 11 (novembro de 2012): 1934578X1200701. http://dx.doi.org/10.1177/1934578x1200701103.
Texto completo da fonteKwon, Eun-Bin, Buyun Kim, Young Soo Kim e Jang-Gi Choi. "Anastrozole Protects against Human Coronavirus Infection by Ameliorating the Reactive Oxygen Species–Mediated Inflammatory Response". Antioxidants 13, n.º 1 (17 de janeiro de 2024): 116. http://dx.doi.org/10.3390/antiox13010116.
Texto completo da fonteAl Mosawi, AJ. "Remdesivir Research Progress: An Overview of the Emerging Evidence". Journal of Biomedical Research & Environmental Sciences 1, n.º 6 (14 de outubro de 2020): 216–18. http://dx.doi.org/10.37871/jbres1146.
Texto completo da fonteBuchowicz, Włodzimierz, e Mariola Koszytkowska-Stawińska. "How Much Potential Do Nucleoside Analogs Offer to Combat Human Corona Viruses?" Organics 5, n.º 2 (8 de maio de 2024): 71–110. http://dx.doi.org/10.3390/org5020006.
Texto completo da fonteChen, Lili, Chunshan Gui, Xiaomin Luo, Qingang Yang, Stephan Günther, Elke Scandella, Christian Drosten et al. "Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro". Journal of Virology 79, n.º 11 (1 de junho de 2005): 7095–103. http://dx.doi.org/10.1128/jvi.79.11.7095-7103.2005.
Texto completo da fontePasquereau, Sébastien, Zeina Nehme, Sandy Haidar Ahmad, Fadoua Daouad, Jeanne Van Assche, Clémentine Wallet, Christian Schwartz, Olivier Rohr, Stéphanie Morot-Bizot e Georges Herbein. "Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro". Viruses 13, n.º 2 (23 de fevereiro de 2021): 354. http://dx.doi.org/10.3390/v13020354.
Texto completo da fonteLan, Qiaoshuai, Chao Wang, Jie Zhou, Lijue Wang, Fanke Jiao, Yanbo Zhang, Yanxing Cai, Lu Lu, Shuai Xia e Shibo Jiang. "25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses". International Journal of Molecular Sciences 22, n.º 21 (1 de novembro de 2021): 11869. http://dx.doi.org/10.3390/ijms222111869.
Texto completo da fonteSong, Yabin, Yongqiang Deng, Huiqiang Wang, Zhuchun Bei, Hongjing Gu, Hui Zhao, Hong Wang et al. "Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro". Molecules 27, n.º 3 (21 de janeiro de 2022): 712. http://dx.doi.org/10.3390/molecules27030712.
Texto completo da fonteLiu, Weiyong, Min Zhang, Chengxiu Hu, Huijuan Song, Yi Mei, Yingle Liu e Qi Zhang. "Remdesivir Derivative VV116 Is a Potential Broad-Spectrum Inhibitor of Both Human and Animal Coronaviruses". Viruses 15, n.º 12 (23 de novembro de 2023): 2295. http://dx.doi.org/10.3390/v15122295.
Texto completo da fonteTusell, Sonia M., Stephanie A. Schittone e Kathryn V. Holmes. "Mutational Analysis of Aminopeptidase N, a Receptor for Several Group 1 Coronaviruses, Identifies Key Determinants of Viral Host Range". Journal of Virology 81, n.º 3 (8 de novembro de 2006): 1261–73. http://dx.doi.org/10.1128/jvi.01510-06.
Texto completo da fonteCalistri, Arianna, Anna Luganini, Barbara Mognetti, Elizabeth Elder, Giulia Sibille, Valeria Conciatori, Claudia Del Vecchio et al. "The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses". Microorganisms 9, n.º 8 (14 de agosto de 2021): 1731. http://dx.doi.org/10.3390/microorganisms9081731.
Texto completo da fonteBege, Miklós, Alexandra Kiss, Ilona Bereczki, Jan Hodek, Lenke Polyák, Gábor Szemán-Nagy, Lieve Naesens, Jan Weber e Anikó Borbás. "Synthesis and Anticancer and Antiviral Activities of C-2′-Branched Arabinonucleosides". International Journal of Molecular Sciences 23, n.º 20 (19 de outubro de 2022): 12566. http://dx.doi.org/10.3390/ijms232012566.
Texto completo da fonteShahhamzehei, Nasim, Sara Abdelfatah e Thomas Efferth. "In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library". Pharmaceuticals 15, n.º 3 (3 de março de 2022): 308. http://dx.doi.org/10.3390/ph15030308.
Texto completo da fonteAmbrosino, Annalisa, Annalisa Chianese, Carla Zannella, Simona Piccolella, Severina Pacifico, Rosa Giugliano, Gianluigi Franci et al. "Galdieria sulphuraria: An Extremophilic Alga as a Source of Antiviral Bioactive Compounds". Marine Drugs 21, n.º 7 (28 de junho de 2023): 383. http://dx.doi.org/10.3390/md21070383.
Texto completo da fonteObermann, Wiebke, Alexandra Friedrich, Ramakanth Madhugiri, Paul Klemm, Jan Philipp Mengel, Torsten Hain, Stephan Pleschka et al. "Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity". Viruses 14, n.º 3 (3 de março de 2022): 519. http://dx.doi.org/10.3390/v14030519.
Texto completo da fonteAl Ibrahim, Malak, Zachee Louis Evariste Akissi, Lowiese Desmarets, Gabriel Lefèvre, Jennifer Samaillie, Imelda Raczkiewicz, Sevser Sahpaz et al. "Discovery of Anti-Coronavirus Cinnamoyl Triterpenoids Isolated from Hippophae rhamnoides during a Screening of Halophytes from the North Sea and Channel Coasts in Northern France". International Journal of Molecular Sciences 24, n.º 23 (22 de novembro de 2023): 16617. http://dx.doi.org/10.3390/ijms242316617.
Texto completo da fonteShishkova, Kalina, Antoniya Stoymirska, Radoslav Chayrov, Stoyan Shishkov, Hristina Sbirkova-Dimitrova, Rusi Rusew, Boris Shivachev e Ivanka Stankova. "Amantadine and Rimantadine Analogues—Single-Crystal Analysis and Anti-Coronaviral Activity". Crystals 13, n.º 9 (14 de setembro de 2023): 1374. http://dx.doi.org/10.3390/cryst13091374.
Texto completo da fonteAndreu, Sabina, Inés Ripa, Raquel Bello-Morales e José Antonio López-Guerrero. "Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro". Viruses 15, n.º 4 (15 de abril de 2023): 972. http://dx.doi.org/10.3390/v15040972.
Texto completo da fontePiacentini, Sara, Anna Riccio, Silvia Santopolo, Silvia Pauciullo, Simone La Frazia, Antonio Rossi, Jean-Francois Rossignol e M. Gabriella Santoro. "The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein". Frontiers in Microbiology 14 (29 de agosto de 2023). http://dx.doi.org/10.3389/fmicb.2023.1206951.
Texto completo da fonteCai, Yanxing, Wei Xu, Jiayi Tang, Najing Cao, Qiaoshuai Lan, Lu Lu e Shibo Jiang. "A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses". Cell & Bioscience 11, n.º 1 (8 de julho de 2021). http://dx.doi.org/10.1186/s13578-021-00638-w.
Texto completo da fonteElango, Abinaya. "In-vitro Assessment of Antiviral Activity of the Herbo Mineral Capsule, Fema SakthiTM, against Human Coronavirus (HCoV) on VERO Cells". Journal of Communicable Diseases, 16 de março de 2022, 120–23. http://dx.doi.org/10.24321/0019.5138.202219.
Texto completo da fonteBai, Xiyuan, Ashley M. Buckle, Eszter K. Vladar, Edward N. Janoff, Reeti Khare, Diane Ordway, David Beckham et al. "Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19". Scientific Reports 12, n.º 1 (25 de março de 2022). http://dx.doi.org/10.1038/s41598-022-09133-9.
Texto completo da fonteHegazy, Ghada E., Marwa M. Abu-Serie, Nadia A. Soliman, Mohamed Teleb e Yasser R. Abdel-Fattah. "Superior anti-pulmonary viral potential of Natrialba sp. M6-producing surfactin and C50 carotenoid pigment with unveiling its action modes". Virology Journal 20, n.º 1 (30 de outubro de 2023). http://dx.doi.org/10.1186/s12985-023-02215-8.
Texto completo da fontePasquereau, Sébastien, Mathilde Galais, Maxime Bellefroid, Irene Pachón Angona, Stéphanie Morot-Bizot, Lhassane Ismaili, Carine Van Lint e Georges Herbein. "Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro". Scientific Reports 12, n.º 1 (24 de novembro de 2022). http://dx.doi.org/10.1038/s41598-022-24682-9.
Texto completo da fonteSingh, Prachi, Ardra P, Hariprasad V.R., Babu U.V., Mohamed Rafiq e Raghavendra Pralhada Rao. "Screening for Potential Traditional Herbal Inhibitors Against 3-Chymotrypsin-Like Main Protease (3CLpro) from Four Different Coronaviruses-: An in-silico Approach". Coronaviruses 02 (16 de fevereiro de 2021). http://dx.doi.org/10.2174/2666796702666210216142508.
Texto completo da fonteSharwani, Khalid, Ravi Sharma, Madhan Krishnan, Terry Jones, Martin Mayora-Neto, Diego Cantoni, Nigel A. Temperton et al. "Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples". Journal of Infectious Diseases, 23 de junho de 2021. http://dx.doi.org/10.1093/infdis/jiab333.
Texto completo da fonteShapira, Tirosh, Selvarani Vimalanathan, Celine Rens, Virginia Pichler, Sandra Peña-Díaz, Grace Jordana, William Rees et al. "Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication". Molecular Biomedicine 3, n.º 1 (12 de dezembro de 2022). http://dx.doi.org/10.1186/s43556-022-00111-1.
Texto completo da fonteZhang, Yumin, Yuan Sun, Yuanchao Xie, Weijuan Shang, Zhen Wang, Hualiang Jiang, Jingshan Shen, Gengfu Xiao e Leike Zhang. "A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir". Signal Transduction and Targeted Therapy 8, n.º 1 (22 de setembro de 2023). http://dx.doi.org/10.1038/s41392-023-01587-1.
Texto completo da fonteKirby, Emily N., Xavier B. Montin, Timothy P. Allen, Jaslan Densumite, Brooke N. Trowbridge e Michael R. Beard. "CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function". Innate Immunity, 23 de janeiro de 2024. http://dx.doi.org/10.1177/17534259231225611.
Texto completo da fonteYuan, Shuofeng, Xiaopan Gao, Kaiming Tang, Jian-Piao Cai, Menglong Hu, Peng Luo, Lei Wen et al. "Targeting papain-like protease for broad-spectrum coronavirus inhibition". Protein & Cell, 6 de abril de 2022. http://dx.doi.org/10.1007/s13238-022-00909-3.
Texto completo da fonteMorin-Dewaele, Margot, Sophie Bartier, François Berry, Rozenn Brillet, Dennis Salomón López-Molina, Công Trung Nguyễn, Pascale Maille et al. "Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry". Scientific Reports 12, n.º 1 (6 de dezembro de 2022). http://dx.doi.org/10.1038/s41598-022-25399-5.
Texto completo da fonteSandler, Zachary J., Mason R. Firpo, Oreoluwa S. Omoba, Michelle N. Vu, Vineet D. Menachery e Bryan C. Mounce. "Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening". Antimicrobial Agents and Chemotherapy 64, n.º 6 (13 de abril de 2020). http://dx.doi.org/10.1128/aac.00086-20.
Texto completo da fonteYang, Minghui, Chunhui Li, Guoguo Ye, Chenguang Shen, Huiping Shi, Liping Zhong, Yuxin Tian et al. "Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity". Signal Transduction and Targeted Therapy 9, n.º 1 (14 de fevereiro de 2024). http://dx.doi.org/10.1038/s41392-024-01748-w.
Texto completo da fonteZhao, Xu, Zhihui Cao, Xiufu Hua, Luocheng Chen, Tong Wei e Shaozhen Li. "Silver molybdate nanocrystal-reinforced high-performance anti-coronavirus composite polymer coating". AIP Advances 13, n.º 10 (1 de outubro de 2023). http://dx.doi.org/10.1063/5.0163736.
Texto completo da fonteRodríguez-Pulido, Miguel, Eva Calvo-Pinilla, Miryam Polo, Juan-Carlos Saiz, Raúl Fernández-González, Eva Pericuesta, Alfonso Gutiérrez-Adán, Francisco Sobrino, Miguel A. Martín-Acebes e Margarita Sáiz. "Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses". Frontiers in Immunology 14 (29 de março de 2023). http://dx.doi.org/10.3389/fimmu.2023.1166725.
Texto completo da fonteBahgat, Dina M., Haidy A. Gad, Eman Al-Sayed, Sara H. Mahmoud, Ahmed Mostafa, Nadia M. Mahfouz, Omayma A. Eldahshan e Abdel Nasser B. Singab. "Essential Oil of Cestrum diurnum L.: GC/MS Analysis, in vitro and in silico Anti‐HCoV‐229E Effects and Inhibitory Activity against LPS‐Induced Inflammation". Chemistry & Biodiversity, 22 de fevereiro de 2023. http://dx.doi.org/10.1002/cbdv.202201045.
Texto completo da fonteLeón-Gutiérrez, Gabriela, James Edward Elste, Carlos Cabello-Gutiérrez, Cesar Millán-Pacheco, Mario H. Martínez-Gómez, Rafael Mejía-Alvarez, Vaibhav Tiwari e Armando Mejía. "A potent virucidal activity of functionalized TiO2 nanoparticles adsorbed with flavonoids against SARS-CoV-2". Applied Microbiology and Biotechnology, 11 de agosto de 2022. http://dx.doi.org/10.1007/s00253-022-12112-9.
Texto completo da fonteSaiz, Maria Laura, Marta L. DeDiego, Darío López-García, Viviana Corte-Iglesias, Aroa Baragaño Raneros, Ivan Astola, Victor Asensi, Carlos López-Larrea e Beatriz Suarez-Alvarez. "Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity". Clinical Epigenetics 13, n.º 1 (11 de outubro de 2021). http://dx.doi.org/10.1186/s13148-021-01168-5.
Texto completo da fonte